Aortic Arch Related Cerebral Hazard Trial (ARCH) "ARCH"

Completed

Phase 3 Results N/A

Summary of Purpose

The ARCH is a controlled trial with a sequential design and with a prospective, randomized, open-label, blinded-endpoint (PROBE) methodology. The objective is to compare the efficacy and tolerance (net benefit) of two antithrombotic strategies in patients with atherothrombosis of the aortic arch and a recent (less than 6 months) cerebral or peripheral embolic event. Hypothesis: The association of...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 6 July 2012.

1 Feb 2002 6 Oct 2005 1 Dec 2010 1 Jul 2012 1 Jul 2012 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts